Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer

IRF8; T cell exhaustion; antigen presentation; antigen-presenting cell; tumor-associated macrophage.
浏览次数:73 分享:
  • Immunity
  • 26.3
  • 2022 Nov 8;55(11):2044-2058.e5.
  • Mouse
  • 单细胞测序
  • 免疫/内分泌
  • Cells from Lymph Node
  • 免疫/内分泌
  • 巨噬细胞
  • 肿瘤, 癌症, 巨噬细胞
  • DOI: 10.1016/j.immuni.2022.10.002

Abstract

Tumors are populated by antigen-presenting cells (APCs) including macrophage subsets with distinct origins and functions. Here, we examined how cancer impacts mononuclear phagocytic APCs in a murine model of breast cancer. Tumors induced the expansion of monocyte-derived tumor-associated macrophages (TAMs) and the activation of type 1 dendritic cells (DC1s), both of which expressed and required the transcription factor interferon regulatory factor-8 (IRF8). Although DC1s mediated cytotoxic T lymphocyte (CTL) priming in tumor-draining lymph nodes, TAMs promoted CTL exhaustion in the tumor, and IRF8 was required for TAMs' ability to present cancer cell antigens. TAM-specific IRF8 deletion prevented exhaustion of cancer-cell-reactive CTLs and suppressed tumor growth. Tumors from patients with immune-infiltrated renal cell carcinoma had abundant TAMs that expressed IRF8 and were enriched for an IRF8 gene expression signature. Furthermore, the TAM-IRF8 signature co-segregated with CTL exhaustion signatures across multiple cancer types. Thus, CTL exhaustion is promoted by TAMs via IRF8. Keywords: IRF8; T cell exhaustion; antigen presentation; antigen-presenting cell; tumor-associated macrophage.
金课堂之文献解析 文献原文请点击

技术文章 更多

    研究领域 更多

      热点文献